Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
abide therapeutics
allergan
amylin pharmaceuticals
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
ben cravatt
bluebird bio
boston
boston blog main
boston top stories
botox
bristol-myers squibb
clinical trials
duchenne muscular dystrophy
dyne therapeutics
epilepsy
executives
facioscapulohumeral muscular dystrophy
gabapentin
gene therapy
hiring
joshua brumm
kaleido biosciences
kevin finney
life science
muscular dystrophy
myotonic dystrophy type 1
nabriva
national top stories
nestlé health science
neurontin
new york blog main
people
pfizer
What
diseases
2
×
medicines
therapeutics
2
×
abide
ago
appointed
biotechs
chief
considering
data
developing
drug
dyne
early
executive
expected
experimental
eyes
finney
genetic
having
humans
ipo
ipos
kevin
long
muscle
neurological
officer
operating
president
rare
reach
tapped
treat
worked
zavante
Language
unset
Current search:
diseases
×
therapeutics
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President